Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Einolf, Heidi J.
32  Ergebnisse:
Personensuche X
?
1

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythm..:

Uddin, Muhammad Erfan ; Eisenmann, Eric D. ; Li, Yang...
International Journal of Molecular Sciences.  23 (2022)  15 - p. 8607 , 2022
Link: https://doi.org/10.3390/..
 
?
2

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythm..:

Uddin, Muhammad Erfan ; Eisenmann, Eric D ; Li, Yang...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20363.  , 2022
Link: https://opus4.kobv.de/op..
 
?
3

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythm..:

Muhammad Erfan Uddin ; Eric D. Eisenmann ; Yang Li...
Molecular Pharmacology.  , 2022
Link: https://doi.org/10.3390/..
 
?
4

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythm..:

Uddin, Muhammad Erfan ; Eisenmann, Eric D ; Li, Yang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369325/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythm..:

Muhammad Erfan Uddin ; Eric D. Eisenmann ; Yang Li...
https://www.mdpi.com/1422-0067/23/15/8607.  , 2022
Link: https://doi.org/10.3390/..
 
?
6

Model‐Informed Drug Development for Everolimus Dosing Selec..:

Combes, Francois Pierre ; Einolf, Heidi J. ; Coello, Neva...
CPT: Pharmacometrics & Systems Pharmacology.  9 (2020)  4 - p. 230-237 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Model‐Informed Drug Development for Everolimus Dosing Selec..:

Francois Pierre Combes ; Heidi J. Einolf ; Neva Coello...
https://doi.org/10.1002/psp4.12502.  , 2020
Link: https://doi.org/10.1002/..
 
?
8

Recommendations for the Design of Clinical Drug–Drug Intera..:

Chen, Yuan ; Cabalu, Tamara D. ; Callegari, Ernesto...
CPT: Pharmacometrics & Systems Pharmacology.  8 (2019)  9 - p. 685-695 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Recommendations for in vitro CYP3A4 mRNA data analysis for ..:

Tweedie, Donald ; Kenny, Jane R. ; Ramsden, Diane...
Drug Metabolism and Pharmacokinetics.  34 (2019)  1 - p. S44 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Practical Assessment of Clinical Drug–Drug Interactions in ..:

Shebley, Mohamad ; Einolf, Heidi J.
Clinical Pharmacology & Therapeutics.  105 (2019)  6 - p. 1326-1328 , 2019
Link: https://doi.org/10.1002/..
 
?
11

Evaluation of the time-course of CYP Induction and impact o..:

Hariparsad, Niresh ; Einolf, Heidi ; Buckley, David...
Drug Metabolism and Pharmacokinetics.  34 (2019)  1 - p. S40 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Recommendations for the Design of Clinical Drug–Drug Intera..:

Chen, Yuan ; Cabalu, Tamara D ; Callegari, Ernesto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765698/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Recommendations for the Design of Clinical Drug–Drug Intera..:

Yuan Chen ; Tamara D. Cabalu ; Ernesto Callegari...
https://doi.org/10.1002/psp4.12449.  , 2019
Link: https://doi.org/10.1002/..
 
?
14

Considerations from the IQ induction working group in respo..:

Hariparsad, Niresh ; Einolf, Heidi ; Kenny, Jane...
Drug Metabolism and Pharmacokinetics.  33 (2018)  1 - p. S52 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Physiologically Based Pharmacokinetic Model Qualification a..:

Shebley, Mohamad ; Sandhu, Punam ; Emami Riedmaier, Arian...
Clinical Pharmacology & Therapeutics.  104 (2018)  1 - p. 88-110 , 2018
Link: https://doi.org/10.1002/..
 
1-15